Cangrelor | Search results | NICE

Showing 1 to 2 of 2 results for cangrelor

Sort by

Coronary revascularisation: Cangrelor (ESNM63)
Summary of the evidence on cangrelor for coronary revascularisation to inform local NHS planning and decision-making
Result type
Evidence summary
Published
3 November 2015
Cangrelor for reducing atherothrombotic events in people undergoing percutaneous coronary intervention or awaiting surgery requiring interruption of anti‑platelet therapy (terminated appraisal) (TA351)
NICE is unable to make recommendations about the use of cangrelor for reducing atherothrombotic events in people undergoing percutaneous coronary…
Result type
Technology appraisal guidance
Published
22 July 2015
Show all sections
Sections for TA351